Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population

James Jones, James A. Weddell, Carol G. McKown

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures. Severe degrees of gingival overgrowth can affect the patient's dentition by: 1) interference with normal masticatory function to the point of documented weight loss, 2) producing an ectopically erupting dentition to the point of poor occlusal development, and 3) producing an unattractive appearance, in those patients who appreciate their esthetics, to the point of lessened self-concept.1 The purpose of this investigation was to evaluate the management of a group of 142 patients, with various cerebral palsy diagnoses, as to the use of diphenylhydantoin for the control of seizures. If diphenylhydantoin was used, the presence, degree, and surgical management of PIGO was documented. Additionally, if surgical treatment was employed for removal of hyperplastic gingiva, the indications for outpatient treatment (no use of general anesthetic) or inpatient (hospital admission and use of a general anesthetic) were identified. A discussion of major indications of surgery and postoperative complications of all surgical procedures is provided.

Original languageEnglish
Pages (from-to)385-390
Number of pages6
JournalJournal of Oral and Maxillofacial Surgery
Volume46
Issue number5
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Gingival Overgrowth
Phenytoin
Cerebral Palsy
Incidence
General Anesthetics
Dentition
Population
Seizures
Gingiva
Esthetics
Weight Loss
Inpatients
Outpatients
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Dentistry(all)

Cite this

Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population. / Jones, James; Weddell, James A.; McKown, Carol G.

In: Journal of Oral and Maxillofacial Surgery, Vol. 46, No. 5, 1988, p. 385-390.

Research output: Contribution to journalArticle

@article{726cbf3cf4c6499b8380da35bee77083,
title = "Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population",
abstract = "Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures. Severe degrees of gingival overgrowth can affect the patient's dentition by: 1) interference with normal masticatory function to the point of documented weight loss, 2) producing an ectopically erupting dentition to the point of poor occlusal development, and 3) producing an unattractive appearance, in those patients who appreciate their esthetics, to the point of lessened self-concept.1 The purpose of this investigation was to evaluate the management of a group of 142 patients, with various cerebral palsy diagnoses, as to the use of diphenylhydantoin for the control of seizures. If diphenylhydantoin was used, the presence, degree, and surgical management of PIGO was documented. Additionally, if surgical treatment was employed for removal of hyperplastic gingiva, the indications for outpatient treatment (no use of general anesthetic) or inpatient (hospital admission and use of a general anesthetic) were identified. A discussion of major indications of surgery and postoperative complications of all surgical procedures is provided.",
author = "James Jones and Weddell, {James A.} and McKown, {Carol G.}",
year = "1988",
doi = "10.1016/0278-2391(88)90222-4",
language = "English",
volume = "46",
pages = "385--390",
journal = "Journal of Oral and Maxillofacial Surgery",
issn = "0278-2391",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Incidence and indications for surgical management of phenytoin-induced gingival overgrowth in a cerebral palsy population

AU - Jones, James

AU - Weddell, James A.

AU - McKown, Carol G.

PY - 1988

Y1 - 1988

N2 - Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures. Severe degrees of gingival overgrowth can affect the patient's dentition by: 1) interference with normal masticatory function to the point of documented weight loss, 2) producing an ectopically erupting dentition to the point of poor occlusal development, and 3) producing an unattractive appearance, in those patients who appreciate their esthetics, to the point of lessened self-concept.1 The purpose of this investigation was to evaluate the management of a group of 142 patients, with various cerebral palsy diagnoses, as to the use of diphenylhydantoin for the control of seizures. If diphenylhydantoin was used, the presence, degree, and surgical management of PIGO was documented. Additionally, if surgical treatment was employed for removal of hyperplastic gingiva, the indications for outpatient treatment (no use of general anesthetic) or inpatient (hospital admission and use of a general anesthetic) were identified. A discussion of major indications of surgery and postoperative complications of all surgical procedures is provided.

AB - Phenytoin-induced gingival overgrowth (PIGO) is a recognized side effect in many cerebral palsy patients using diphenylhydantoin (Dph) for the control of seizures. Severe degrees of gingival overgrowth can affect the patient's dentition by: 1) interference with normal masticatory function to the point of documented weight loss, 2) producing an ectopically erupting dentition to the point of poor occlusal development, and 3) producing an unattractive appearance, in those patients who appreciate their esthetics, to the point of lessened self-concept.1 The purpose of this investigation was to evaluate the management of a group of 142 patients, with various cerebral palsy diagnoses, as to the use of diphenylhydantoin for the control of seizures. If diphenylhydantoin was used, the presence, degree, and surgical management of PIGO was documented. Additionally, if surgical treatment was employed for removal of hyperplastic gingiva, the indications for outpatient treatment (no use of general anesthetic) or inpatient (hospital admission and use of a general anesthetic) were identified. A discussion of major indications of surgery and postoperative complications of all surgical procedures is provided.

UR - http://www.scopus.com/inward/record.url?scp=0023930008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023930008&partnerID=8YFLogxK

U2 - 10.1016/0278-2391(88)90222-4

DO - 10.1016/0278-2391(88)90222-4

M3 - Article

C2 - 3163372

AN - SCOPUS:0023930008

VL - 46

SP - 385

EP - 390

JO - Journal of Oral and Maxillofacial Surgery

JF - Journal of Oral and Maxillofacial Surgery

SN - 0278-2391

IS - 5

ER -